These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23112960)

  • 1. Novel approaches to develop Rift Valley fever vaccines.
    Indran SV; Ikegami T
    Front Cell Infect Microbiol; 2012; 2():131. PubMed ID: 23112960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate vaccines for human Rift Valley fever.
    Ikegami T
    Expert Opin Biol Ther; 2019 Dec; 19(12):1333-1342. PubMed ID: 31478397
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rift valley fever vaccines.
    Ikegami T; Makino S
    Vaccine; 2009 Nov; 27 Suppl 4():D69-72. PubMed ID: 19837291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
    Indran SV; Lihoradova OA; Phoenix I; Lokugamage N; Kalveram B; Head JA; Tigabu B; Smith JK; Zhang L; Juelich TL; Gong B; Freiberg AN; Ikegami T
    J Gen Virol; 2013 Jul; 94(Pt 7):1441-1450. PubMed ID: 23515022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
    Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
    Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.
    Matsiela MS; Naicker L; Khoza T; Mokoena N
    Virol J; 2023 Oct; 20(1):221. PubMed ID: 37789354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
    Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
    J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on rift valley fever virus and vaccines in Egypt.
    Ahmed Kamal S
    Virol J; 2011 Dec; 8():532. PubMed ID: 22152149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
    Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
    Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
    Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.